Carson Wealth (CWM LLC)
ANIP icon

Carson Wealth (CWM LLC)’s ANI Pharmaceuticals ANIP Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.8K Buy
777
+1
+0.1% +$78 ﹤0.01% 3678
2025
Q4 		$61K Sell
776
-22
-3% -$1.91K ﹤0.01% 3442
2025
Q3 		$73K Buy
798
+490
+159% +$40K ﹤0.01% 3214
2025
Q2 		$20K Buy
308
+216
+235% +$14.1K ﹤0.01% 3894
2025
Q1 		$6K Buy
92
+33
+56% +$1.97K ﹤0.01% 4336
2024
Q4 		$3K Buy
59
+25
+74% +$1.44K ﹤0.01% 4378
2024
Q3 		$2K Sell
34
-17
-33% -$1.04K ﹤0.01% 4350
2024
Q2 		$3K Buy
51
+46
+920% +$2.99K ﹤0.01% 4029
2024
Q1 		$0 Buy
5
+2
+67% +$121 ﹤0.01% 4292
2023
Q4 		$0 Hold
3
– – ﹤0.01% 4108
2023
Q3 		$0 Hold
3
– – ﹤0.01% 4157
2023
Q2 		$0 Hold
3
– – ﹤0.01% 4154
2023
Q1 		$0 Hold
3
– – ﹤0.01% 4021
2022
Q4 		$0 Buy
+3
New +$113 ﹤0.01% 3952
2022
Q2 		– Sell
-329
Closed -$9K – 3759
2022
Q1 		$9K Sell
329
-11
-3% -$410 ﹤0.01% 2516
2021
Q4 		$16K Buy
+340
New +$14.6K ﹤0.01% 2099
2021
Q2 		$0 Hold
5
– – ﹤0.01% 2925
2021
Q1 		$0 Hold
5
– – ﹤0.01% 2925
2020
Q4 		$0 Hold
5
– – ﹤0.01% 2925
2020
Q3 		$0 Hold
5
– – ﹤0.01% 2925
2020
Q2 		$0 Hold
5
– – ﹤0.01% 2925
2020
Q1 		$0 Hold
5
– – ﹤0.01% 2925
2019
Q4 		$0 Hold
5
– – ﹤0.01% 2924
2019
Q3 		$0 Hold
5
– – ﹤0.01% 2924
2019
Q2 		$0 Hold
5
– – ﹤0.01% 2924
2019
Q1 		$0 Hold
5
– – ﹤0.01% 2932
2018
Q4 		$0 Hold
5
– – ﹤0.01% 2081
2018
Q3 		$0 Hold
5
– – ﹤0.01% 1831
2018
Q2 		$0 Hold
5
– – ﹤0.01% 1685
2018
Q1 		$0 Hold
5
– – ﹤0.01% 1397
2017
Q4 		$0 Hold
5
– – ﹤0.01% 1447
2017
Q3 		$0 Hold
5
– – ﹤0.01% 1461
2017
Q2 		$0 Buy
+5
New +$241 ﹤0.01% 1193

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ANIP Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its ANI Pharmaceuticals (ANIP) stake by 0.13% in Q1 2026, buying an estimated $78 and bringing the position to 777 shares worth $59.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3678.

Carson Wealth (CWM LLC) first reported a position in ANIP in Q2 2017 and has held it in 33 quarters since. The position peaked at $73K in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Carson Wealth (CWM LLC) held 777 shares of ANI Pharmaceuticals worth $59.8K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1 ANI Pharmaceuticals share in Q1 2026, an estimated $78.
  • ANI Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3678 holding.
  • Carson Wealth (CWM LLC) first reported a position in ANI Pharmaceuticals in Q2 2017 and has held it in 33 quarters since.
  • Carson Wealth (CWM LLC)'s ANI Pharmaceuticals position peaked at $73K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.